Archive: Company News
BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
— Market entry under new EU regulations for medical devices
— Spearheading the commercialization of 3D-printed regenerative medicine products
BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, today announced that the Company has received authorization for its custom-made bone and pectus excavatum scaffolds in Europe under EU medical devices regulations
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
– Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off
Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced that the Company has been awarded an initial grant of €2.5 million combined with an additional equity funding of up to €10 million under the European Innovation Council (EIC) Accelerator program sponsored by the European Union.
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
— Acquisition of EK-Pack latest investment to bolster commitment to customers throughout Europe.
Oliver Healthcare Packaging, a leading supplier of sterile barrier flexible packaging solutions to the global healthcare market, today announced the acquisition of EK-Pack Folien GmbH, a manufacturer of high-quality film and foil technology, located in Ermengerst-Wiggensbach, Bavaria, Germany. This acquisition includes Vacopack H. Buchegger AG, a fully owned subsidiary of EK-Pack, based in northeastern Switzerland. Read more…
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
– First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally
– Enrollment ongoing in Germany, Spain, the Netherlands, and the United Kingdom
Dopavision, a clinical-stage company developing innovative solutions for the management of myopia, today announced an update on its MyopiaX-1 trial (NCT04967287). All clinical trial centers are now open and are actively screening and enrolling study participants, providing trial access to eligible children with myopia across Germany, Spain, the Netherlands, and the United Kingdom.